Healthcare
Combating non-communicable diseases / Stringent tobacco control a crying need
Speakers comprising health experts and physicians yesterday called for stringent control on use of tobacco products in order to combat the alarming rise of non-communicable diseases.
World leaders commit to decisive action on AMR
Globl leaders have approved a political declaration at the 79th United Nations General Assembly (UNGA) High-Level Meeting on Antimicrobial Resistance (AMR), committing to targets including a 10% reduction in the estimated 4.95 million deaths associated with bacterial AMR by 2030.
Navigating the postpartum journey
The postpartum period, often considered the first six weeks after childbirth, is a transformative time filled with physical and emotional changes as new mothers adjust to life with their newborns. While this period can feel overwhelming, it is important to recognise that every woman’s experience
Does my medical condition affect my anger?
Experiencing anger is a natural part of being human, but frequent and intense outbursts can harm both your health and relationships. Understanding the possible underlying medical reasons for your anger can help you address the issue effectively. .Dementia and anger .Various forms of
Unlocking the Sun’s potential: How daylight influences physical activity and mood in depression
Seasonal changes can significantly impact mood, especially for individuals with mood disorders like major depressive disorder and bipolar disorder. Many people notice their symptoms worsen during darker, shorter days, but the precise reasons for this have long been unclear.
World Rabies Day: A call to action
Every year on September 28, the world observes World Rabies Day, a vital occasion aimed at raising awareness about the prevention of rabies and highlighting progress in combating this deadly disease.
Untreated hypertension increases dementia risk
Dementia is one of the most feared outcomes of ageing, affecting millions of individuals and their families worldwide. While genetics and age play significant roles, other modifiable risk factors have garnered attention, particularly hypertension. For years, researchers have explored the complex relationship between high blood pressure and cognitive decline, increasingly recognising hypertension as a major contributor to dementia risk.
More than 39 million deaths from antibiotic-resistant infections estimated between now and 2050, suggests first global analysis
More than 39 million deaths from antibiotic-resistant infections could occur by 2050, according to the first global analysis of antimicrobial resistance (AMR) trends.
COVID-19 reinfection uncommon, but older adults seem at higher risk
The risk for reinfection with SARS-CoV-2 is generally low, but it is higher among adults aged 65 and older, according to a population-based study from Denmark published in The Lancet.
Mental health aftermath of COVID-19: long-hauler depression?
Recent surveys during the COVID-19 pandemic have documented substantial rates of depression, anxiety, and overall distress in as many as one-third
Lead poisoning and stunting in Bangladesh: a missing link
Long-term malnutrition might at first seem like a medical condition and its remedial measures easy, using balanced diet, appropriate for age, along
World TB Day 2021: The clock is ticking
More than a century has passed since the March 24, 1882, announcement by Robert Koch that Mycobacterium tuberculosis (Mtb) bacteria cause
Draft regulations on trans fatty acids opened for public consultation
In order to safeguard public health, the draft regulations on “Limiting Trans Fatty Acid in Food Products Regulations, 2021” has been uploaded for public consultation on the website of Bangladesh Food Safety Authority.
New statistical model predicts which cities could become “super-spreaders”
Researchers have developed a new statistical model that predicts which cities are more likely to become infectious disease hotspots, based both on interconnectivity between cities and the idea that some cities are more suitable environments for infection than others.
Amyloid-targeted treatment seems to slow progression of Alzheimer’s
Donanemab is associated with a modest slowing of Alzheimer disease progression in patients with early symptomatic disease, according to an industry-conducted phase 2 trial published in the New England Journal of Medicine and presented at the International Conference on Alzheimer’s and Parkinson’s Disease.
COVID-19 vaccines: AstraZeneca issued statement on blood clots
AstraZeneca issued a statement recently to reassure the public about the safety of its COVID-19 vaccine after several European Union (EU) countries halted its use over concerns about blood clots.
Vitamin D deficiency during COVID-19: a paediatric perspective
Vitamin D deficiency is one of the most prevalent micronutrient deficiencies in the world. It has emerged as a public health problem in many developing countries of the world including Bangladesh.
Colorectal cancer: Mass awareness is the key
Advertisements for haemorrhoids, fistula and treatments for these diseases are a common sight glued on walls and pillars on our way back and forth home.